One of psychiatry’s most consequential underrecognized truths: OCD requires higher SSRI doses than depression. The standard “starting dose” used for depression often produces no meaningful OCD response — yet most OCD patients never get titrated to the doses that actually work.
According to American Psychiatric Association OCD treatment guidelines, evidence-based OCD treatment typically requires 2-3 times the typical antidepressant doses, and adequate trials require 12-16 weeks at maximum tolerated dose before evaluating response. Most OCD patients are dosed and trial-timed for depression — and labeled “non-responsive” before they’ve actually received an adequate OCD trial.
The Dosing Difference
For depression, typical effective SSRI doses are:
- Sertraline: 50-100 mg
- Fluoxetine: 20-40 mg
- Escitalopram: 10-20 mg
- Paroxetine: 20-40 mg
For OCD, evidence-based doses typically reach:
- Sertraline: 150-200 mg (often higher)
- Fluoxetine: 60-80 mg
- Escitalopram: 20-30 mg
- Paroxetine: 40-60 mg
- Fluvoxamine: 200-300 mg (often the most OCD-specific)
These higher doses are FDA-approved or evidence-supported for OCD specifically. They’re not “extreme” — they’re standard for the condition. But because primary care and many general psychiatrists are less familiar with OCD-specific dosing, patients commonly never reach therapeutic levels.
Why Higher Doses
OCD biology involves more profound serotonergic dysfunction than depression. The brain circuits involved (cortico-striato-thalamo-cortical loop) appear to require greater serotonergic modulation to achieve clinical response. Higher receptor occupancy is needed.
This isn’t theoretical — dose-response studies consistently show better OCD outcomes at the higher doses. Going up to maximum tolerated dose is part of the evidence-based protocol.
The Trial Duration Issue
Beyond dose, OCD trials need to be longer. For depression, 6-8 weeks at therapeutic dose is typically enough to evaluate response. For OCD, evidence-based protocols call for 12-16 weeks at maximum tolerated dose before declaring a medication ineffective.
Many OCD patients have stopped multiple medications at 4-6 weeks because they weren’t seeing improvement — when adequate response often emerges at 10-12 weeks at proper dose.
Combined with Exposure and Response Prevention (ERP)
Medication alone produces meaningful improvement in many OCD patients, but combination with ERP — the gold-standard psychotherapy for OCD — produces better outcomes than either alone. ERP is delivered by specially trained therapists; Dr. Farkas coordinates medication management with ERP therapists.
Source: Bloch et al., meta-analyses of OCD pharmacotherapy.
What If High-Dose SSRI Doesn’t Work?
After adequate high-dose SSRI trials, options include:
- Clomipramine — tricyclic with strong serotonergic effects, often effective when SSRIs aren’t
- Augmentation — low-dose atypical antipsychotic (risperidone, aripiprazole) augmentation has substantial evidence
- Combined with intensive ERP — for patients without prior intensive exposure work
- Specialist OCD programs — residential or intensive outpatient programs
- Deep brain stimulation — for severe, treatment-refractory cases
- TMS — FDA-approved for OCD as of 2018
Inadequate dosing and trials
Most OCD patients labeled “treatment-resistant” have never received adequate OCD-specific doses or trial durations — they’re labeled non-responsive before truly being trialed.
OCD-specific protocols
Dr. Farkas uses evidence-based OCD doses and trial durations, with willingness to push to maximum tolerated dose and evaluate at proper timepoints.
Real OCD response
Patients dosed properly for OCD often see substantial improvement that prior treatment never produced.
Common Questions About OCD Treatment
Are higher doses dangerous?
No more so than standard doses. SSRIs at OCD doses are well-tolerated by most patients. Side effects increase modestly but remain manageable. The risk is not titrating up — leaving patients on subtherapeutic doses with untreated illness.
How long should I be on OCD medication?
Typically at least 12-24 months after achieving remission. Premature discontinuation has high relapse rates. Long-term treatment is often appropriate.
Will I need to combine medication with therapy?
Combined treatment produces the best outcomes. ERP therapy alongside medication is the evidence-based standard. See our related article on OCD.
What if I can’t tolerate high doses?
Some patients tolerate fluoxetine or sertraline better at higher doses; others do better with escitalopram or paroxetine. Trial of different SSRIs at proper OCD doses, or alternative agents like clomipramine, may be needed.